RBM3 and bladder transitional cell carcinoma: The association between RBM3 expression and a favorable clinical outcome has been demonstrated in several other cancer forms [6-10] but this is, to our knowledge, the first report of the prognostic impact of RBM3 expression in urothelial bladder cancer.